For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Summary
Market Segment as follows:
By Region
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
By Type
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
By Application
- Diagnostics
- Therapeutics Development
- Research and Development
- Other Applications
By Company
- AM Biotechnologies, LLC (U.S.)
- Aptagen, LLC (U.S.)
- Aptamer Sciences, Inc. (South Korea)
- Aptamer Solutions Ltd. (U.K.)
- Aptus Biotech S.L. (Spain)
- Base Pair Biotechnologies, Inc. (U.S.)
- NeoVentures Biotechnology, Inc. (Canada)
- SomaLogic, Inc. (U.S.)
- TriLink BioTechnologies, Inc. (U.S.)
- Vivonics, Inc. (U.S.)
The main contents of the report including:
Section 1: Product definition, type and application, global and regional market overview;
Section 2: Global and regional Market competition by company;
Section 3: Global and regional sales revenue, volume and price by type;
Section 4: Global and regional sales revenue, volume and price by application;
Section 5: Regional export and import;
Section 6: Company information, business overview, sales data and product specifications;
Section 7: Industry chain and raw materials;
Section 8: SWOT and Porter's Five Forces;
Section 9: Conclusion.